176 related articles for article (PubMed ID: 36779496)
1. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
Alradhi M; Wen S; Safi M; Al-Danakh A; Wang H; Shopit A; Sun M; Fan B; Li X
Cancer Med; 2023 Feb; 12(4):3931-3951. PubMed ID: 36779496
[TBL] [Abstract][Full Text] [Related]
2. The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
Wang J; Wang FW; Kessinger A
World J Urol; 2012 Dec; 30(6):777-83. PubMed ID: 21706144
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
4. Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.
Jin D; Qiu S; Jin K; Zhou X; Cao Q; Yang L; Wei Q
Front Oncol; 2020; 10():653. PubMed ID: 32500022
[No Abstract] [Full Text] [Related]
5. An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case.
Lendorf ME; Dohn LH; Á Dunga B; Loya AC; Pappot H
Scand J Urol; 2018 Apr; 52(2):87-93. PubMed ID: 29291665
[TBL] [Abstract][Full Text] [Related]
6. A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.
Liu L; Li C; Wang Q; Yuan H; Wang Y
Eur J Med Res; 2023 Feb; 28(1):61. PubMed ID: 36732873
[TBL] [Abstract][Full Text] [Related]
7. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Signet-Ring Cell Carcinoma of the Bladder in Cerebrospinal Fluid.
Lin DM; Park JW; Gattuso P
Diagn Cytopathol; 2017 Jan; 45(1):73-76. PubMed ID: 27629260
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
11. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
12. Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.
Wu SG; Chen XT; Zhang WW; Sun JY; Li FY; He ZY; Pei XQ; Lin Q
Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):209-214. PubMed ID: 29227748
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and ultrastructural characterization of the signet-ring cell carcinoma component in a case of urothelial carcinoma of the urinary bladder.
Ohtsuki Y; Fukumoto T; Okada Y; Teratani Y; Hayashi Y; Lee GH; Furihata M
Med Mol Morphol; 2010 Jun; 43(2):96-101. PubMed ID: 20683697
[TBL] [Abstract][Full Text] [Related]
14. [Stage pT1 signet ring cell carcinoma of the urinary bladder: a case report].
Matsuzaki A; Kobayashi Y; Suzuki K; Morita T; Tokue A
Hinyokika Kiyo; 2000 Feb; 46(2):127-30. PubMed ID: 10769804
[TBL] [Abstract][Full Text] [Related]
15. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
Wang J; Wang FW
Urol Int; 2011; 86(4):453-60. PubMed ID: 21525723
[TBL] [Abstract][Full Text] [Related]
17. Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study.
Alradhi M; Safi M; Tao S; Al-Danakh A; Almoiliqy M; Baldi S; Li X
Ther Adv Urol; 2022; 14():17562872221079473. PubMed ID: 35422880
[TBL] [Abstract][Full Text] [Related]
18. Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA.
Zaffuto E; Gazdovich S; Leyh-Bannurah SR; Huland H; Abdollah F; Shariat SF; Menon M; Briganti A; Montorsi F; Karakiewicz PI
Int J Urol; 2017 Feb; 24(2):117-123. PubMed ID: 27875858
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
